Focus on Cellulosic Biofuel Development and Commercialization of Diversified Industrial Enzyme Portfolio CAMBRIDGE, Mass. and SAN DIEGO, June 20 /PRNewswire-FirstCall/ -- Diversa Corporation...
SAN DIEGO, June 12 /PRNewswire-FirstCall/ -- Favrille, Inc. (NASDAQ:FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced...
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA), a leader in the development of high-performance specialty enzymes, announced today that it has achieved two...
CAMBRIDGE, Mass., May 11 /PRNewswire-FirstCall/ -- Celunol Corp., a leader in the development of cellulosic ethanol, announced today that members of its management will participate in four...
Delivers Record Quarterly Product-Related Revenue, With 111% Increase Compared to First Quarter 2006 SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA), a leader in...
CAMBRIDGE, Mass., April 19 /PRNewswire/ -- Celunol Corp., a leader in the development of cellulosic ethanol, announced today that members of its management will participate in three upcoming...
SAN DIEGO, March 30 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA) announced today that the initial purchasers have exercised in full their over-allotment option to purchase an...
SAN DIEGO, March 28 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA) announced today the closing of its previously announced offering of $100 million aggregate principal amount of...
SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA), a leader in the development of high-performance specialty enzymes, announced today that its Form 10-K filed with...
SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA) announced today the pricing of its private placement of $100.0 million aggregate principal amount of 5.50...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관